Larvol Delta - Safety-and-Efficacy-of-TareSphere-in-Patients-With-Unresectable-Hepatocellular-Carcinoma

NRT6003 - Chengdu New Radiomedicine Technology

http://clinicaltrials.gov/ct2/show/NCT06310590

Feb 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next